<![CDATA[Antares Pharma Inc. | Company News & Executive Profiles - AIS | BNET]]> en-us <![CDATA[Antares Receives a Notice of Allowance for U.S. Patent Covering Anturol™]]> Wed, 04 Jun 2008 23:59:59 -0700 AIS AIS <![CDATA[Antares Pharma Announces Notice of Allowance for Newest ATD™ Gel Patent]]> Wed, 21 Feb 2007 23:59:59 -0800 AIS AIS <![CDATA[Antares Pharma Announces Notice of Allowance for Elestrin™ Patent by U.S. Patent & Trademark Office]]> Wed, 07 Feb 2007 23:59:59 -0800 AIS AIS <![CDATA[Roth Capital Partners 18th Annual Growth Stock Conference Presenter Profiles]]> Fri, 17 Feb 2006 23:59:59 -0800 ARGN AIS APPY AXTI BNT BBCZ CLRT CGPI DFCL Q DIO ERI GORX MCVI MMSI MIDD NDAQ NEOG NTCT PPHM ZICA ARGN,AIS,APPY,AXTI,BNT,BBCZ,CLRT,CGPI,DFCL Q,DIO,ERI,GORX,MCVI,MMSI,MIDD,NDAQ,NEOG,NTCT,PPHM,ZICA <![CDATA[Techvest 7th Annual Healthcare Conference Presenter Profiles]]> Fri, 04 Nov 2005 23:59:59 -0800 AKSY AIS ARQL CYTR DSCO ENMD IYXI MIIS NDAQ OLGC OXGN STEM VQPH AKSY,AIS,ARQL,CYTR,DSCO,ENMD,IYXI,MIIS,NDAQ,OLGC,OXGN,STEM,VQPH <![CDATA[Rubicon Global Research Announces Investment Opinion: Rubicon Global Research, LLC is Initiating Coverage on Antares Pharma Inc., with a Speculative Strong-Buy Rating and a Near Term Price Target of $3.50]]> Tue, 06 Sep 2005 23:59:59 -0700 AIS NDAQ AIS,NDAQ